[1]张明,李雅莉,杨侠,等.血清糖类抗原125在慢性阻塞性肺疾病急性加重期中的临床意义[J].南方医科大学学报,2016,(10):1386.
点击复制

血清糖类抗原125在慢性阻塞性肺疾病急性加重期中的临床意义()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2016年10期
页码:
1386
栏目:
出版日期:
2016-10-15

文章信息/Info

Title:
Clinical significance of serum carbohydrate antigen 125 in acute exacerbation of chronic obstructive pulmonary disease
作者:
张明李雅莉杨侠单虎张秋红冯向莉谢颖颖唐晶晶张洁
关键词:
慢性阻塞性肺疾病肺动脉高压急性加重期糖类抗原125脑钠肽
Keywords:
chronic obstructive pulmonary disease pulmonary hypertension acute exacerbation carbohydrate antigen 125 brain natriuretic peptide
摘要:
目的探讨糖类抗原125(CA125)在慢性阻塞性肺疾病急性加重期(AECOPD)患者血清中的表达水平及其与肺动脉高压 的关系。方法根据肺功能和心脏彩超结果将研究对象分为3组:AECOPD合并肺动脉高压组(46例)、单纯AECOPD组(46例) 和健康对照组(38例)。收集所有研究对象的临床资料、肺功能和心脏彩超,并测定肺肿瘤标志物全套和脑钠肽(BNP)的血清学 水平。结果与健康对照组相比,AECOPD合并肺动脉高压组、单纯AECOPD组的肺功能显著下降,且AECOPD合并肺动脉高 压组的肺功能最差(P<0.05)。单纯AECOPD组患者的血清CA125较健康对照组显著升高,当合并肺动脉高压时进一步升高 (P<0.05);而其它肺肿瘤标志物(癌胚抗原、神经元特异性烯醇化酶、非小细胞肺癌相关抗原和胃泌素释放肽前体)在3组之间比 较无统计学差异(P>0.05)。AECOPD合并肺动脉高压组患者的血清BNP水平亦显著高于单纯AECOPD组(P<0.05)。Pearson 直线相关性分析显示,AECOPD合并肺动脉高压组患者的血清CA125与肺动脉收缩压及BNP均呈正相关(P<0.01)。结论血 清CA125可能被用于判断AECOPD是否合并肺动脉高压的一个血清学指标。
Abstract:
Objective To study the serum level of carbohydrate antigen 125 (CA125) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and its relation with pulmonary hypertension. Methods Forty-six patients with AECOPD complicated by pulmonary hypertension, 46 with AECOPD and 38 healthy control subjects were examined for their clinical data, pulmonary function, echocardiographic findings, and serum levels of lung tumor markers and brain natriuretic peptide (BNP). Results Compared with the healthy control group, COPD patients with or without pulmonary hypertension showed significantly decreased pulmonary function (P<0.05), especially in those with AECOPD and concurrent pulmonary hypertension (P<0.05). Serum CA125 level was obviously higher in AECOPD group than in the healthy control group, and further increased in AECOPD patients with pulmonary hypertension (P<0.05). The levels of lung tumor markers (CEA, NSE, CYFRA and PROGRP) were similar among the 3 groups (P>0.05). The serum level of BNP in patients with AECOPD and concurrent pulmonary hypertension was significantly higher than that in patients with AECOPD (P<0.05). Pearson linear correlation analysis showed that serum CA125 was positively correlated with pulmonary artery systolic pressure and BNP in AECOPD patients with pulmonary hypertension (P<0.01). Conclusion Serum CA125 may serve as a serological index to identify AECOPD patients with pulmonary hypertension.

相似文献/References:

[1]周露茜,黎晓莹,李允,等.呼吸肌肉锻炼加序贯无创正压通气在稳定期重度慢阻肺患者中的应用:临床随机对照试验[J].南方医科大学学报,2016,(08):1069.
[2]陈怡静,邓春玉,邝素娟,等.慢性阻塞性肺疾病病人肺内小动脉对血栓素及内皮素的反应性降低[J].南方医科大学学报,2013,(03):360.
[3]孙嘉,郑晶晶,郭松文,等.微型营养评定法在老年慢性阻塞性肺疾病患者中的应用及其与BODE指数的相关性[J].南方医科大学学报,2013,(08):1217.
[4]应少聪,周向东,周丽华,等.运动训练联合心理激励对慢性阻塞性肺疾病患者生活质量的影响[J].南方医科大学学报,2013,(09):1312.
[5]谢新明,王小闯,张永红,等.COPD继发性肺动脉高压患者血清中几种生物学活性物质的变化[J].南方医科大学学报,2013,(10):1458.
[6]吴媛媛,王贵佐,李满祥.肺动脉平滑肌细胞增殖的分子信号机制研究进展[J].南方医科大学学报,2013,(12):1852.
[7]叶卫华,李伯君,盛炜,等.波生坦治疗先天性心脏病相关肺动脉高压的临床疗效[J].南方医科大学学报,2014,(12):1846.
[8]柯蕊,吴媛媛,王贵佐,等.胰岛素抵抗与肺动脉高压关系的研究进展[J].南方医科大学学报,2015,(02):301.
[9]李允,李寅环,罗裕文,等.吸入短效支气管舒张剂对慢性阻塞性肺疾病患者等二氧化碳高通气过程中膈肌功能和中枢驱动的影响[J].南方医科大学学报,2016,(02):232.
[10]吕燕华,朱顺芳,曾小莉,等.5次“起-坐”试验在慢性阻塞性肺疾病患者临床评价中的价值[J].南方医科大学学报,2016,(04):477.

更新日期/Last Update: 1900-01-01